Akari Therapeutics Issues 2025 End of Year Letter to Shareholders

TAMPA, Fla. and LONDON, Dec. 30, 2025 (GLOBE NEWSWIRE) -- Akari Therapeutics, Plc (Nasdaq: AKTX), an oncology biotechnology ...
腾讯网

同行致远 | 里程碑！siRNA疗法为这类疾病带来新希望 | Bilingual

编者按：2025年，siRNA疗法在治疗凝血相关疾病的研究方面取得了重要里程碑进展。RNA干扰（RNAi）机制通过在肝脏细胞中沉默编码凝血因子或天然抗凝物的mRNA，为治疗凝血相关疾病提供了一种全新的治疗模式。基于GalNAc偶联的递送技术，是将治疗 ...

Akari Therapeutics Plc: Akari Therapeutics Issues 2025 End of Year Letter to Shareholders

Akari Therapeutics, Plc (Nasdaq: AKTX), an oncology biotechnology company developing antibody drug conjugates (ADCs) with novel payloads today ...

RedHook’s Alex Powys Talks 10 Drummers Who Influenced His Playing On ‘Mutation’

Paying homage to Parkway Drive's Ben Gordon, Polaris's Dan Furnari, Stray From The Path's Craig Reynolds & more The post RedHook’s Alex Powys Talks 10 Drummers Who Influenced His Playing On ‘Mutation’ ...
eLife

Retrosplenial cortex enables context-dependent goal-directed sensorimotor transformation

This important study combines optogenetic manipulations and wide-field imaging to show that the retrosplenial cortex controls behavioral responses to whisker deflection in a context-dependent manner.